carmustine has been researched along with Diabetes Mellitus in 2 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wilson, GL | 1 |
| Mossman, BT | 1 |
| Craighead, JE | 1 |
| Schouten, HC | 1 |
| Maragos, D | 1 |
| Vose, J | 1 |
| Armitage, JO | 1 |
2 other studies available for carmustine and Diabetes Mellitus
| Article | Year |
|---|---|
Use of pancreatic beta cells in culture to identify diabetogenic N-nitroso compounds.
Topics: Animals; Carmustine; Cells, Cultured; Cytological Techniques; Diabetes Mellitus; Insulin; Islets of | 1983 |
Diabetes mellitus or an impaired glucose tolerance as a potential complicating factor in patients treated with high-dose therapy and autologous bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Carmustine; Cyclophosphamide; Cytarabine; Diabetes Mellitus; Dos | 1990 |